PHYSIOMEGA
ActiveSummary
PHYSIOMEGA has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €102,816 and a net result of €18,969. Equity is growing by ~40% per year across the filed fiscal years. Its solvency ranks better than 30% of 2386 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability77▼-4
Solvency60▲+1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8,000 at 30 days acceptable
Liquidity short (current ratio 0.99 against 0.77 in 2024; short-term debt: 31.6% and cash: 27.3% of total assets), and 64.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
35.5%
Return on assets
6.5%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-08-2026, 4 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
4 d late
2024
19 d late
2023
51 d early
2022
33 d early
2021
8 d late
2020
22 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 13 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 4 August (4 of the last 5 filed years within 37 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€102,816▲ 22.6%
2024 · €83,847
Total assets
€289,914▲ 18.3%
2024 · €245,166
Net result
€18,969▼ 19.5%
2024 · €23,557
Working capital
-€737▲ 96.8%
2024 · -€23,178
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€17,493▲ 11.6%€13,487▼ 22.9%€38,468▲ 185%€32,716▼ 15.0%€24,982▼ 23.6%
Net result€13,196below the sector's middle half▲ 28.0%€8,215below the sector's middle half▼ 37.8%€25,471within the sector's middle half▲ 210%€23,557within the sector's middle half▼ 7.5%€18,969below the sector's middle half▼ 19.5%
Equity€26,505below the sector's middle half▲ 99.2%€34,720below the sector's middle half▲ 31.0%€60,191within the sector's middle half▲ 73.4%€83,847within the sector's middle half▲ 39.3%€102,816within the sector's middle half▲ 22.6%
Total assets€161,878within the sector's middle half▲ 156%€179,813within the sector's middle half▲ 11.1%€212,973within the sector's middle half▲ 18.4%€245,166within the sector's middle half▲ 15.1%€289,914below the sector's middle half▲ 18.3%
Debt€135,373▲ 171%€145,093▲ 7.2%€152,782▲ 5.3%€161,319▲ 5.6%€187,098▲ 16.0%
Working capital-€44,195below the sector's middle half▼ 198%-€45,556below the sector's middle half▼ 3.1%-€35,632below the sector's middle half▲ 21.8%-€23,178below the sector's middle half▲ 35.0%-€737below the sector's middle half▲ 96.8%
Solvency16.4%below the sector's middle half▼ 4.7pp19.3%below the sector's middle half▲ 2.9pp28.3%below the sector's middle half▲ 9.0pp34.2%below the sector's middle half▲ 5.9pp35.5%within the sector's middle half▲ 1.3pp
Current ratio0.27below the sector's middle half▼ 0.300.40below the sector's middle half▲ 0.120.60below the sector's middle half▲ 0.200.77below the sector's middle half▲ 0.180.99below the sector's middle half▲ 0.22
Return on assets (ROA)8.2%below the sector's middle half▼ 8.2pp4.6%below the sector's middle half▼ 3.6pp12.0%within the sector's middle half▲ 7.4pp9.6%within the sector's middle half▼ 2.4pp6.5%within the sector's middle half▼ 3.1pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 24% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €289,914
Fixed assets
€199,172 ▲ 19.5%
Current assets
€90,742 ▲ 15.6%
Equity and liabilities €289,914
Equity
€102,816 ▲ 22.6%
Debt
€187,098 ▲ 16.0%
Debt's share of the balance-sheet total falls from 65.8% to 64.5%. Equity and debt are higher.
Key figures and ratios
EBITDA
€38,357▼
2024 · €53,024
Cash flow
€32,344▼
2024 · €43,865
Debt to equity
1.82▼
2024 · 1.92
ROE
18.4%▼
2024 · 28.1%
Interest coverage
30.98▼
2024 · 53.18
Debt ≤ 1 year
€91,479▼
2024 · €101,684
Debt > 1 year
€91,887▲
2024 · €59,635
Income taxes
€4,775▼
2024 · €7,952
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €3,000 | - | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €5,403 | €14,237 | €17,689 | €20,308 | €13,375 | ▼ 34.1% |
| Other operating charges640/8 | €1,074 | €2,659 | €870 | €1,102 | €1,291 | ▲ 17.2% |
| Gross operating margin9900 | €23,970 | €30,383 | €57,027 | €54,125 | €39,648 | ▼ 26.7% |
| Operating profit (loss)9901 | €17,493 | €13,487 | €38,468 | €32,716 | €24,982 | ▼ 23.6% |
| Financial income75/76B | €1,711 | - | - | - | - | - |
| Recurring financial income75 | €250 | - | - | - | - | - |
| Non-recurring financial income76B | €1,461 | - | - | - | - | - |
| Financial charges65/66B | €2,281 | €1,161 | €1,048 | €1,206 | €1,238 | ▲ 2.6% |
| Recurring financial charges65 | €2,281 | €1,161 | €1,048 | €997 | €1,238 | ▲ 24.2% |
| Non-recurring financial charges66B | - | - | - | €209 | - | - |
| Profit (loss) for the period before taxes9903 | €16,923 | €12,326 | €37,420 | €31,509 | €23,744 | ▼ 24.6% |
| Income taxes67/77 | €3,727 | €4,112 | €11,949 | €7,952 | €4,775 | ▼ 40.0% |
| Profit (loss) for the period9904 | €13,196 | €8,215 | €25,471 | €23,557 | €18,969 | ▼ 19.5% |
| Profit (loss) for the period to be appropriated9905 | €13,196 | €8,215 | €25,471 | €23,557 | €18,969 | ▼ 19.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €161,878 | €179,813 | €212,973 | €245,166 | €289,914 | ▲ 18.3% |
| Fixed assets21/28 | €145,394 | €150,010 | €160,540 | €166,660 | €199,172 | ▲ 19.5% |
| Intangible fixed assets21 | €20,835 | €31,881 | €47,493 | €59,704 | €49,835 | ▼ 16.5% |
| Tangible fixed assets22/27 | €124,559 | €118,129 | €113,046 | €106,956 | €149,337 | ▲ 39.6% |
| Land and buildings22 | €97,168 | €97,168 | €101,769 | €101,290 | €100,810 | ▼ 0.5% |
| Plant, machinery and equipment23 | €473 | €2,023 | €1,666 | €2,069 | €2,461 | ▲ 19.0% |
| Furniture and vehicles24 | €26,918 | €18,938 | €9,612 | €3,598 | €1,962 | ▼ 45.5% |
| Other tangible fixed assets26 | - | - | - | - | €44,105 | - |
| Current assets29/58 | €16,484 | €29,803 | €52,434 | €78,506 | €90,742 | ▲ 15.6% |
| Amounts receivable within one year40/41 | €1,373 | €1,388 | €1,425 | €6,571 | €10,372 | ▲ 57.8% |
| Other amounts receivable41 | €1,373 | €1,388 | €1,425 | €6,571 | €10,372 | ▲ 57.8% |
| Cash at bank and in hand54/58 | €4,593 | €26,390 | €49,217 | €70,472 | €79,073 | ▲ 12.2% |
| Deferred charges and accrued income490/1 | €10,518 | €2,025 | €1,792 | €1,463 | €1,297 | ▼ 11.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €161,878 | €179,813 | €212,973 | €245,166 | €289,914 | ▲ 18.3% |
| Equity10/15 | €26,505 | €34,720 | €60,191 | €83,847 | €102,816 | ▲ 22.6% |
| Contributions10/11 | €3,000 | €3,000 | €3,000 | €3,000 | €3,000 | = |
| Capital10 | €3,000 | - | - | - | - | - |
| Issued capital100 | €3,000 | - | - | - | - | - |
| Outside capital11 | - | €3,000 | €3,000 | €3,000 | €3,000 | = |
| Other1109/19 | - | €3,000 | €3,000 | €3,000 | €3,000 | = |
| Reserves13 | €23,505 | €31,720 | €57,191 | €80,847 | €99,816 | ▲ 23.5% |
| Distributable reserves133 | €23,505 | €31,720 | €57,191 | €80,847 | €99,816 | ▲ 23.5% |
| Amounts payable17/49 | €135,373 | €145,093 | €152,782 | €161,319 | €187,098 | ▲ 16.0% |
| Amounts payable after more than one year17 | €74,693 | €69,733 | €64,716 | €59,635 | €91,887 | ▲ 54.1% |
| Financial debts170/4 | €74,693 | €69,733 | €64,716 | €59,635 | €91,887 | ▲ 54.1% |
| Amounts payable within one year42/48 | €60,680 | €75,359 | €88,066 | €101,684 | €91,479 | ▼ 10.0% |
| Current portion of amounts payable after more than one year42 | €4,900 | €4,960 | €5,017 | €5,081 | €9,233 | ▲ 81.7% |
| Trade debts44 | €89 | €1,082 | €1,268 | €1,373 | €1,349 | ▼ 1.8% |
| Suppliers440/4 | €89 | €1,082 | €1,268 | €1,373 | €1,349 | ▼ 1.8% |
| Taxes, remuneration and social security45 | €1,684 | - | - | - | - | - |
| Taxes450/3 | €1,684 | - | - | - | - | - |
| Other amounts payable47/48 | €54,007 | €69,318 | €81,781 | €95,230 | €80,897 | ▼ 15.1% |
| Accrued charges and deferred income492/3 | - | - | - | - | €3,732 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €13,196 | €8,215 | €25,471 | €23,557 | €18,969 | ▼ 19.5% |
| + Depreciation and write-downs630 | €5,403 | €14,237 | €17,689 | €20,308 | €13,375 | ▼ 34.1% |
| Operating cash flow (approximation) | €18,599 | €22,452 | €43,160 | €43,865 | €32,344 | ▼ 26.3% |
| Investment in fixed assets (approximation) | - | -€18,853 | -€28,219 | -€26,428 | -€45,887 | ▼ 73.6% |
| Change in cash | - | €21,796 | €22,827 | €21,255 | €8,601 | ▼ 59.5% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 4 days late
2025
31-12
Financial
Equity above €100,000Eq €102,816 ▲22.6%
6 profitable years in a row build equity to €102,816.
19-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 19 days late
2024
10-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2020net €25,471 ▲210%
Operating result €38,468, net result €25,471, both a record.
28-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €8,215 ▼37.8%
Net result drops to €8,215, the lowest in the series; recovery starts the following year.
08-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 8 days late
2021
09-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mettet · 1 establishment unit since 2020
Ground area
2,291 m²
Building footprint
375 m²
Volume, LiDAR
2,959 m³
Parcel 92087K0191/00G000, Wallonia · tallest building 16.7 m, ±3 floors. Linked by address, not a title deed.
10
companies at this address
See who is registered here
1 establishment unit
PHYSIOMEGA
since 20202.299.809.424
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92087K0191/00G000 | Wallonia | 2,291 m² | 1 · 375 m² | 16.7 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ARFEVI
BE 0712.661.770
Kortrijk · Eq €102,800
CETHIURO
BE 0478.556.329
Gerpinnes · Eq €102,843
De Praktijk KH
BE 0696.841.169
Knokke-Heist · Eq €102,903
CARDIOLOGIE AZ DELTA
BE 0545.787.128
Roeselare · Eq €102,705
N-EURO
BE 1023.099.778
Wezembeek-Oppem · Eq €102,570
Of 16,627 companies in sector 86220 we hold annual accounts for 7,988. 6,361 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded23-01-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
85592Vocational training
Contact
E-mail
KRAMBOUSSANOSNICOLAS@gmail.com
Phone
+32491254001
E-invoicing
Reachable via Peppol
Peppol ID
0208:0741949436
Also
9925:BE0741949436
Registered
08-01-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.